Patent application number | Description | Published |
20080227809 | Arylalkylamine Vanadium (V) Salts for the Treatment and/or Prevention of Diabetes Mellitus - This invention provides compounds and pharmaceutical compositions thereof for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes. | 09-18-2008 |
20090298923 | Salicylate Conjugates Useful for Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 12-03-2009 |
20100234452 | Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 09-16-2010 |
20100239552 | Combination Therapies for Treating Metabolic Disorders - This invention is directed to pharmaceutical combinations comprising an antioxidant agent, an anti-inflammatory agent, and optionally at least one other anti-diabetic agent useful for treating metabolic disorders. This invention also encompasses pharmaceutically acceptable compositions comprising an antioxidant agent, an anti-inflammatory agent, optionally at least one other anti-diabetic agent, and at least one pharmaceutically acceptable carrier. The combinations and compositions of this invention are useful as methods for treating metabolic disorders including diabetes, particularly Type I and Type II diabetes, as well as diseases and disorders associated with diabetes, including but not limited to atherosclerosis, cardiovascular disease, inflammatory disorders, nephropathy, neuropathy, retinopathy, β-cell dysfunction, dyslipidemia, LADA, metabolic syndrome, hyperglycemia, insulin resistance, and/or chronic obstructive pulmonary disease in a mammal, particularly a diabetic mammal, and specifically a human patient. This invention is particularly directed to pharmaceutical compositions comprising an lipoic acid, one or more anti-inflammatories selected from the group consisting of diflunisal, diclofenac, dexibuprofen, dexketoprofen, naproxen, and salicylate, and optionally one or more pharmaceutically acceptable carriers. The compositions of this invention are useful as methods for treating metabolic disorders including type II diabetes, insulin resistance, beta-cell dysfunction, and hyperglycemia in a patient, particularly a diabetic patient. | 09-23-2010 |
20120149769 | Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders - The invention is directed to thiocarbonate compounds of Formula (I)-(III) and methods of treating atherosclerosis, neuropathy, nephropathy, retinopathy, inflammatory disorders, COPD, cardiovascular diseases, metabolic disorders, type I diabetes mellitus, type II diabetes mellitus, LADA, Wolfram Syndrome 1, Wolcott-Rallison syndrome, metabolic syndrome, dyslipidemia, hyperglycemia, or insulin resistance. The compounds of the invention are also useful for protecting pancreatic beta-cells and for reducing free fatty acids, triglycerides, advanced glycated end products, ROS, lipid peroxidation, tissue and plasma TNFalpha and IL6 levels, or for delaying or preventing cardiovascular complications associated with atherosclerosis. | 06-14-2012 |
20130267726 | Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders - The invention is directed to thiocarbonate compounds of Formula (I)-(III) and methods of treating atherosclerosis, neuropathy, nephropathy, retinopathy, inflammatory disorders, COPD, cardiovascular diseases, metabolic disorders, type I diabetes mellitus, type II diabetes mellitus, LADA, Wolfram Syndrome 1, Wolcott-Rallison syndrome, metabolic syndrome, dyslipidemia, hyperglycemia, or insulin resistance. The compounds of the invention are also useful for protecting pancreatic beta-cells and for reducing free fatty acids, triglycerides, advanced glycated end products, ROS, lipid peroxidation, tissue and plasma TNFalpha and IL6 levels, or for delaying or preventing cardiovascular complications associated with atherosclerosis. | 10-10-2013 |
20130281413 | Salicylate Conjugates Useful For Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 10-24-2013 |
20130281520 | Anti-Inflammatory And Antioxidant Conjugates Useful For Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 10-24-2013 |
20140357602 | Combination Therapies For Treating Metabolic Disorders - This invention is directed to pharmaceutical combinations comprising an antioxidant agent, an anti-inflammatory agent, and optionally at least one other anti-diabetic agent useful for treating metabolic disorders. This invention also encompasses pharmaceutically acceptable compositions comprising an antioxidant agent, an anti-inflammatory agent, optionally at least one other anti-diabetic agent, and at least one pharmaceutically acceptable carrier. The combinations and compositions of this invention are useful as methods for treating metabolic disorders including diabetes, particularly Type I and Type II diabetes, as well as diseases and disorders associated with diabetes, including but not limited to atherosclerosis, cardiovascular disease, inflammatory disorders, nephropathy, neuropathy, retinopathy, β-cell dysfunction, dyslipidemia, LADA, metabolic syndrome, hyperglycemia, insulin resistance, and/or chronic obstructive pulmonary disease in a mammal, particularly a diabetic mammal, and specifically a human patient. This invention is particularly directed to pharmaceutical compositions comprising an lipoic acid, one or more anti-inflammatories selected from the group consisting of diflunisal, diclofenac, dexibuprofen, dexketoprofen, naproxen, and salicylate, and optionally one or more pharmaceutically acceptable carriers. The compositions of this invention are useful as methods for treating metabolic disorders including type II diabetes, insulin resistance, beta-cell dysfunction, and hyperglycemia in a patient, particularly a diabetic patient. | 12-04-2014 |
20150025006 | Pharmaceutical Combinations Including Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders - One aspect of the present invention is a pharmaceutical combination comprising (a) an anti-inflammatory agent/anti-oxidant agent conjugate; and (b) an insulin secretogogue, an insulin sensitizer, an alpha-glucosidase inhibitor, a peptide analog, or a combination thereof. Another aspect of the invention relates to methods of treating metabolic disorders with such conjugates. | 01-22-2015 |
Patent application number | Description | Published |
20140004834 | SYSTEM AND METHOD FOR GESTURE-BASED MANAGEMENT | 01-02-2014 |
20140006219 | COUNTEROFFER GENERATION SERVICE | 01-02-2014 |
20140007008 | TECHNIQUES FOR SELECT-HOLD-RELEASE ELECTRONIC DEVICE NAVIGATION MENU SYSTEM | 01-02-2014 |
20140134972 | Embedding Service Provider Information In A Wireless Call - In one embodiment, a method includes receiving, in a mobile station of a terminating party, an incoming call and an identifier of a service provider of an initiating party of the incoming call, and displaying information corresponding to the initiating party service provider on a display of the mobile station. Other embodiments are described and claimed. | 05-15-2014 |
20140172828 | PERSONALIZED SEARCH LIBRARY BASED ON CONTINUAL CONCEPT CORRELATION - A system, devices, and methods for providing a personalized search library based on continual concept correlation include a client computing device and a personalized content server. Content events representing content accessed or manipulated by a user of the client computing device are continually generated. Content associated with the content events is continually parsed and analyzed to extract main concepts. The extracted concepts are correlated and weighted into a concept model, based on the order of the content events. The concept model parallels the structure of the user's memory. Data sources are continually searched for content relevant to a current context of the concept model. Relevant content is indexed according to the concept model. The relevant content may be made available to the user upon request or proactively. Relevant content may be cached for future use by the user. Other embodiments are described and claimed. | 06-19-2014 |
20140200025 | LOCATION DISCREPANCY CORRECTIONS BASED ON COMMUNITY CORRECTIONS AND TRAJECTORY DETECTION - Generally, this disclosure describes location discrepancy fixes using a community of users. A method may include correcting a location of a mobile device when a location signal is lost based on a last known location and a trajectory, wherein a corrected location corresponds to an actual location provided by at least one user of a community of users and stored in a list of corrected locations, and the actual location is related to the last known location and the trajectory. | 07-17-2014 |
20140221003 | PEER-BASED COLLABORATIVE DISCOVERY AND SIGNALING OF ANOTHER DEVICE IN LIMITED-SIGNAL AREAS - Generally, this disclosure describes a method and system for peer-based collaborative discovery and signaling of another device in limited signal areas. A method may include, in an embodiment, initiating a sensing mode in a seek mobile device in response to receiving an indication that a location of a lost mobile device is unknown; capturing first position data if a signal from the lost device is detected; capturing second position data in response to losing the signal from the lost device; and determining an estimated location of the lost device based on the first position data and the second position data, wherein the lost device is located in an area of limited or no connectivity and the seek device is moving through the area. | 08-07-2014 |
20140273962 | CALL HANDLING BASED ON USER PROFILE IDENTIFICATION - Technologies for handling a call based on user identification include determining a personal profile identification for a user of a communal mobile communication device and initiating a call to a personal communication device using a phone number of the personal communication device and the personal profile identification. The personal communication device may apply a call treatment to the incoming call based on the personal profile identification. Additionally, the personal communication device may originate a call to a call recipient of the communal mobile communication device using a personal profile identification to identify the call recipient. The communal mobile communication device may apply a call treatment to the incoming call based on the personal profile identification. | 09-18-2014 |
20140282679 | DYNAMICALLY IMPLEMENTING AN IMAGE PROTECTION POLICY - Technologies for dynamically implementing an image protection policy include a camera device with a camera to capture an image of at least one person. The camera device determines a location in the image of at least one person in the image, determines a location of at least one personal computing device, and maps the personal computing devices to the persons captured in the image based on the determined device and image locations. The camera device may broadcast an announcement of the creation of the image to the personal computing devices, negotiate an image protection policy with each of the personal computing devices, and implement the negotiated image protection policy. | 09-18-2014 |
Patent application number | Description | Published |
20100234660 | REGENERATION OF CATALYSTS FOR DEHYDRATING ALKANES - The invention relates to a method for dehydrating alkanes, wherein the alkane is guided in a reactor for the dehydrogenation of alkanes via a catalyst, and the process may be carried out adiabatically or non-adiabatically, and the catalyst for dehydration can be regenerated after the reaction phase by means of transferring a gas, wherein said gas is guided via the catalyst after a short rinsing phase using water vapor, and said regeneration gas consists of a gas containing oxygen and of steam, and after regeneration the catalyst is freed of the gas containing oxygen by transferring steam, wherein the duration of the transfer of a gas containing oxygen is significantly reduced as compared to common methods and represents 70% or less of the total regeneration time, and the catalyst has an increased selectivity for forming alkene by means of carrying out the regeneration at a constant activity, and the catalyst is comprised of a metal of the group of platinum metals or group VIB of the periodic table of the elements, which is applied to a carrier in form of a compound or in elementary form, which substantially consists of oxides of the elements of tin, zinc, or aluminum. | 09-16-2010 |
20110144400 | HIGHLY POROUS FOAM CERAMICS AS CATALYST CARRIERS FOR THE DEHYDROGENATION OF ALKANES - The invention relates to a material which is suited as a carrier for catalysts in the dehydrogenation of alkanes and in the oxidative dehydrogenation of alkanes and which is made of an oxide ceramic foam and may contain combinations of the substances aluminium oxide, calcium oxide, silicon dioxide, tin oxide, zirconium dioxide, calcium aluminate, zinc aluminate, silicon carbide, and which is impregnated with one or several suitable catalytically active materials, by which the flow resistance of the catalyst decreases to a considerable degree and the accessibility of the catalytically active material improves significantly and the thermal and mechanical stability of the material increases. The invention also relates to a process for the manufacture of the material and a process for the dehydrogenation of alkanes by using the material according to the invention. | 06-16-2011 |
20110301392 | VARIATION OF TIN IMPREGNATION OF A CATALYST FOR ALKANE DEHYDROGENATION - A catalyst for the dehydrogenation of alkanes or alkyl substituents of hydrocarbons, is a shaped body having at least one oxide from the elements of the main or secondary group II to IV of the periodic table or of a mixed oxide thereof serving as base material of the shaped body. The catalyst further contains an additional constituent which is an oxide of an element of the main group IV of the periodic table, added during the shaping process. A platinum compound and a compound of an element of the main group IV of the periodic table is used as a surface constituent of the catalyst. The invention further relates to the production of the catalyst and to a method for the dehydrogenation of alkanes using the catalyst. | 12-08-2011 |